Related Experiment Video

Updated: Jun 13, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Pharmaco-epigenomics: discovering therapeutic approaches and biomarkers for cancer therapy

B Claes1, I Buysschaert, D Lambrechts

  • 1Vesalius Research Center, VIB and K.U. Leuven, Campus Gasthuisberg, Leuven, Belgium.

Heredity
|April 15, 2010
PubMed

Insights

Cancer pharmaco-epigenomics leverages epigenetic insights for novel therapies and diagnostics. Epigenetic drugs, like DNA methyltransferase and histone deacetylase inhibitors, show promise in cancer treatment and patient stratification.

Area of Science:

  • Oncology
  • Epigenetics
  • Pharmacology

Background:

  • Cancer is characterized by dysregulated gene activity and expression due to genetic and epigenetic alterations.
  • Epigenetic processes are increasingly recognized as key drivers of tumor biology and progression.

Purpose of the Study:

  • To highlight the emergence of cancer pharmaco-epigenomics.
  • To discuss the therapeutic potential of targeting epigenetic machinery in cancer.
  • To explore the utility of epigenetic markers in cancer diagnostics and prognostics.

Main Methods:

  • Review of current research on epigenetic alterations in cancer.
  • Analysis of approved epigenetic therapies, including DNA methyltransferase and histone deacetylase inhibitors.
  • Discussion of the role of epigenetic modifications in tumor microenvironment and stromal cells.

Main Results:

  • Epigenetic interference offers novel therapeutic strategies, with approved DNA methyltransferase and histone deacetylase inhibitors.
  • Epigenetic markers show potential as diagnostic, prognostic, and predictive tools in cancer.
  • Epigenetic therapies can impact tumor-stromal interactions, including tumor-endothelial cells.

Conclusions:

  • Cancer pharmaco-epigenomics is a rapidly developing field with significant therapeutic and diagnostic implications.
  • Targeting epigenetic machinery provides a promising avenue for cancer treatment.
  • Epigenetic markers are valuable for personalized cancer care and understanding tumor biology.

More Related Videos

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues10:41

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues

Published on: April 5, 2018

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...